Trial Profile
Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2018
Price :
$35
*
At a glance
- Drugs Gadobenic acid (Primary) ; Gadoterate-meglumine (Primary)
- Indications Multiple sclerosis
- Focus Diagnostic use
- 19 Dec 2016 New trial record